SCHEMBL2901356

SCHEMBL2901356

COc1ccc(-c2csc(NCCOc3cc(C)c(OC(C)(C)C(=O)O)cc3C)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT3A P56704 1/20 0.47
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
RAB9A P51151 5/20 0.46
LMNA P02545 4/20 0.46
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
MAPT P10636 5/20 0.45
NPC1 O15118 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 3/20 0.45
TP53 P04637 2/20 0.45
CSNK2A1 P68400 1/20 0.45
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
GSTO1 P78417 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2900685 0.97 PTPN1 (0.46) WNT3APPARDPPARASMN1; SMN2RAB9A
SCHEMBL2906469 0.91 PPARD (0.49) PPARDPPARACSNK2A1
SCHEMBL2901183 0.89 PPARD (0.49) PPARDPPARACSNK2A1PTPN1
SCHEMBL2906603 0.89 PPARD (0.48) PPARDPPARAMEN1KMT2AALDH1A1
SCHEMBL2906846 0.88 RAB9A (0.48) WNT3APPARDPPARASMN1; SMN2RAB9A
SCHEMBL2901181 0.86 PPARD (0.47) PPARDPPARARAB9AMEN1KMT2A
SCHEMBL2900976 0.83 PPARD (0.47) PPARDPPARARAB9AMEN1KMT2A
SCHEMBL2904024 0.83 PPARD (0.57) PPARDPPARA
SCHEMBL2901278 0.81 KMT2A (0.47) PPARDPPARARAB9ALMNAMEN1
SCHEMBL2904008 0.81 KMT2A (0.50) PPARDPPARARAB9ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP claimed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US claimed
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP disclosed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR PPARD, PPARG, PPARA WNT3A 2918/4885PPARD 1/4885PPARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.